{
  "docId": "019de06f-55b4-734a-a2e3-c1019ed629b5",
  "docSlug": "42b17c6fff3e2006bf9fc5d84bd6edcc",
  "documentTitle": "Pershing Square | Activist Presentation Deck | 120 slides",
  "authorId": "pershing-square",
  "authorName": "Pershing Square Capital Management, L.P.",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2955465,
  "pageNumber": 23,
  "pageCount": 120,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "preempt_rebuttal",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 64,
  "notes": "Uses red dashed boxes and arrows to draw attention to specific data points (tenure, ownership, committee roles, and voting results) that support the thesis of weak governance.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de06f-55b4-734a-a2e3-c1019ed629b5/23",
  "deckHref": "/decks/019de06f-55b4-734a-a2e3-c1019ed629b5",
  "deckJsonHref": "/decks/019de06f-55b4-734a-a2e3-c1019ed629b5.json",
  "deckAnchorHref": "/decks/019de06f-55b4-734a-a2e3-c1019ed629b5#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "Source: Name, title, tenure, age and committees per Allergan's proxy statement filed with the SEC March 20, 2014. Shares held per FactSet; ISS recommendation per April 23, 2014 ISS report; Glass Lewis recommendation per April 13, 2014 Glass Lewis report; and vote results per Allergan's Form 8-K filed with the SEC May 9, 2014.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ef19323-a56a-4a2a-b75b-0810d48e594b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.65,
        "y": 0.08
      },
      "kind": "legend",
      "text": "Members of Corporate Governance Committee received lower than average shareholder support at the 2014 AGM",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5cc82a6e-7f66-49d9-b8d9-a9ed971b6dbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.4,
        "y": 0.08
      },
      "kind": "legend",
      "text": "No \"skin in the game\", limited alignment with investors",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd06c477-c500-4078-959b-203aa0f445ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.15,
        "y": 0.08
      },
      "kind": "legend",
      "text": "Lengthy tenure may impact independence and objectivity",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fdad7d6f-8b73-4b60-812e-8b4c00e3b954",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "table",
      "text": "Board member details including Name, Title, Tenure, Age, Shares, Committees, and 2014 AGM results.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c64baa3-a3fb-4ebf-97c9-3ece4b1c8815",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Allergan's Board is Characterized by Long Tenures, Low Stock Ownership, and Weak Governance",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec21daa0-c0ce-42c1-9fe6-f58dd033ffc0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "97fa9715-9eb3-4ece-a358-cff49e423a61",
      "evidence": "table/data: Board member details including Name, Title, Tenure, Age, Shares, Committees, and 2014 AGM results.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "governance",
      "slug": null,
      "matchId": "7a2090c3-3e0b-4636-a7bc-b41708a00774",
      "evidence": "Analysis of board composition and shareholder alignment",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 24,
      "from": 9,
      "beatId": "bf928945-d71f-4324-9c3e-615807756058",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Complication",
      "beatSlug": "complication",
      "evidence": "The document highlights Allergan's poor corporate governance and questionable business practices",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}